Using their “Network-based Laplacian regularized Least Square Synergistic drug combination prediction” — or NLLSS — researchers from the Chinese Academy of Sciences in Beijing were experimentally validated seven of 13 predicted antifungal synergistic drug combinations for treating Candida albicans.
“It is anticipated that NLLSS would be an important and useful resource by providing a new strategy to identify potential synergistic antifungal combinations, explore new indications of existing drugs, and provide useful insights into the underlying molecular mechanisms of synergistic drug combinations,” the authors conclude.
The research is published in PLOS Computational Biology.
More articles on infection control:
IDSA updates guidance for invasive mold infections: 5 things to know
Fifth UPMC patient with mold infection dies
Imaging innovation enables easier diagnosis of fungal lung infections
